Novo Nordisk Debuts Wegovy's Oral Pill in a Star-Studded Super Bowl 2025 Ad
Novo Nordisk is set to make its first Super Bowl 2025 appearance with a 90-second commercial for Wegovy. The ad will air during the third quarter of the Super Bowl 2025 on February 8. It marks a bold move in the growing weight-loss drug market, where telehealth brands like Hims & Hers and Ro are also advertising this year.
The commercial will open with actor Kenan Thompson declaring, 'Big news, America! Wegovy now comes in a Super Bowl 2025 pill.' This highlights the company's push for its new oral tablet version of the drug, a shift from the injectable form most people know.
The ad features a star-studded, diverse cast, including DJ Khaled, Danielle Brooks, Ana Gasteyer, John C. Reilly, and Danny Trejo. The long runtime allows time for both the celebrity appearances and the legally required disclosures about potential side effects.
Novo Nordisk sees the Super Bowl 2025 as a chance to spark wider discussions about weight and health. With millions watching, the company hopes the oral tablet format will attract new interest in Wegovy. Meanwhile, telehealth competitors like Hims & Hers and Ro will also run ads during the Super Bowl 2025, targeting the same audience with their own weight management services.
The 90-second spot will be Novo Nordisk's first Super Bowl 2025 advertisement. It arrives as the weight-loss drug market expands, with multiple brands competing for attention. The company's focus on an oral tablet and a high-profile cast signals a push to reach more consumers.
